Home > Boards > US OTC > Medical - Equipment >

MultiCorp International, Inc. (MCIC)

MCIC RSS Feed
Add MCIC Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator sirant, gorbec1, k9narc, MLR_Lite, 4u2nv2, stringofpearls
Search This Board:
Last Post: 7/25/2014 8:55:23 PM - Followers: 520 - Board type: Free - Posts Today: 0
http://multicorpinternational.com


 

Medical

The medical industry has seen many changes in the past few years, and MultiCorp will continue to operate in this sector. When identifying potential acquisitions in this sector, MultiCorp has a significant advantage over other companies looking for qualified businesses.

Our past work with major healthcare companies such as United Healthcare, Kaiser, and Tenet, to name a few, bodes well for MultiCorp's future. As with any new technology in the medical field, working with the actual companies that can pay for the products/services is the key to generating revenue in this sector.

MultiCorp will look to grow its business now and in the future by identifying breakthroughs in the tele-medicine and tele-health sectors, hospital and clinic construction and operations, healthcare insurance and managed professional groups.

The company has submitted bids throughout the world to build and operate several hospitals, clinics, and other similar medical businesses that offer cutting-edge solutions for countries that have been lagging behind in delivering proper medical care.

The company is also looking to penetrate all facets of the Obamacare solutions for patients and companies that are having a hard time navigating this system. Through alliances with healthcare insurers, medical professionals, and software solution companies, MultiCorp expects to grow in the medical sector for many years to come.
 

MULTICORP INTERNATIONAL, INC ENGAGES BIOREGENERATIVE SCIENCES, INC and NORTH COUNTY CLINICAL RESEARCH TO DEVELOP CLINICAL TRIAL PROCEDURES ON PATENTED MIGRAINE MEDICINE

Apr 16, 2014

OTC Disclosure & News Service
Sun Valley, CA -
Procedure Report will Set Stage to begin Clinical Trials on Migraine Medication
April 16, 2014 6:00 AM PT
SUN VALLEY, CA - MultiCorp International, Inc, (OTC Pink: MCIC - News) has engaged Dr. Greg Maguire of BioRegenerative Sciences, Inc along with Dr. Valentin Isacescu of North County Clinical Research to work with the company to develop a clear path to begin clinical trials on their patented migraine medicine for eventual approval by the FDA.
The company released the following statement, "We're extremely excited to have such a qualified and experienced group to assist the company in mapping out a clear strategy for the migraine medication to gain approval from the FDA. While we understand this could be a long process, having a group that is so well versed on the proper procedures clinical trials require to gain approval, we feel we've chosen the perfect group to accomplish this portion of the process in the most expeditious manner possible. Once the report is completed in the next four to six weeks, the company will have a clear understanding as to the requirements from the FDA on beginning clinical trials", stated Mr. Paul D. Lisenby, CEO of MultiCorp International, Inc. Mr. Lisenby added, "We feel this medication could become a major player in the $3.2 billion dollar segment of the migraine pharmaceutical vertical."
Dr. Greg Maguire, CEO of BioRegenerative Sciences, Inc, stated, "Our group is very excited to help bring this important new drug candidate for migraines through the FDA 505(b)(2) NDA approval process. Dr Valentin Isacescu added, "Migraine is such a debilitating disorder for so many patients and a tremendous need exists for a medication to prevent and control this malady."  
About MultiCorp International, Inc.
MultiCorp International, Inc is a diverse company that operates in various business sectors that show true growth potential. The company builds on its executives experience in property development, constructions, medical, hospitality, agribusiness, commodities such as oil and gas, and entertainment. The company looks to expand through acquisitions of solid business models and management that have the potential to grow exponentially. The company will have additional subsidiaries that will eventually grow into being their own public entity, be sold, or continue to operate within MultiCorp. For further information please contact them at info@multicorpinternational.com
 
About BioRegenerative Sciences, Inc.
BioRegenerative Sciences, Inc. is a privately held corporation headquartered in San Diego, CA and currently has fifteen patent pending products on the market and is further developing a portfolio of therapeutic and cosmeceutical products and services based on BRS's core stem cell-based S2RM(R) Technology.  For more information, please email: sales@bioregenerativesciences.com, or call BRS at 858. 521.9203.
 
About North County Clinical Research
North County Clinical Research (NCCR) is a dedicated clinical research site located in the North County of San Diego. We specialize in central nervous system (CNS) indications, some medical indications, drug dependence, alcohol dependence, nicotine dependence, sleep disorders, and chronic pain clinical trials. We are comprised of physicians and research staff with over 20 years of combined experience conducting phase II through phase IV clinical trials. Our site is affiliated with Aurora Behavioral Health Care which provides excellent opportunities for recruitment and inpatient clinical trials.
For more information, please visit their website at http://www.nccresearch.com/







Multicorp International, Inc Acquires 70% Ownership in Patented Migraine Headache Medication

 

Multicorp International, Inc Acquires 70% Ownership in Patented Migraine Headache Medication

Company Seeking Clinical Trial Partner to Begin Testing in First Quarter of 2014

SUN VALLEY, CA--(Marketwired - Dec 17, 2013) - MultiCorp International, Inc, (OTC Pink: MCIC) has acquired a 70% stake in a patented migraine medication. The company released the following statement:

"MultiCorp International, Inc has acquired a 70% ownership in a patented migraine medicine that has shown to aid in the symptoms of migraine headaches. According to www.migraine.com in the U.S. alone more than 37 million people suffer from migraines and globally over 330 million people have migraines on a constant basis. The medication was developed by a physician that MultiCorp will work closely with in order to gain FDA approval for the medication. The company plans to begin clinical trials in the first quarter of 2014 and hope to have the medication to market as soon as possible. The information on the patent can be found at http://www.faqs.org/patents/app/20090018205. Under the terms of the agreement, MultiCorp will have full authority to oversee the clinical trials of the product, marketing and selling of the medication, as well the overall business of getting the product to market as quickly as possible and retaining a 70% interest in the product. With the average cost of $145 per month in medication for migraine sufferers, the market for this product is exponential here in the U.S. and globally."

For companies wishing to assist MultiCorp in clinical trials, please email us at info@multicorpinternational.com

 

 

About MultiCorp International

MultiCorp International, Inc is a diverse company that operates in various business sectors that show true growth potential. The company builds on its executives experience in property development, constructions, medical, and hospitality as well as commodities such as oil and gas, and entertainment.

MultiCorp seeks out and acquires companies in several targeted business fields that have strong potential, seasoned management experience, and show true potential for exponential growth.

While our process may seem simple to some - look for and acquire companies in growth sectors - our standards are set high. A complete due diligence package must be met before any consideration is made to move forward. If, at any time, any component of our criteria is not met, that potential business will not be considered to become part of MultiCorp International, Inc.

MultiCorp will continue to build and grow in the future. Our expansion will be global in nature and the company continues to look at projects/companies throughout the world. The vision of management for MultiCorp is to diversify into many fields wherein management's expertise along with our strategic partners experience will raise the company's bottom line profitability
 

Management

Paul D. Lisenby - Chairman and CEO
Mr. Lisenby has been in the capital markets since 1996. Paul managed a $100 million fund that invested in small cap companies, large indexes as well as private equity funding. In addition, Paul was responsible for negotiating several acquisitions to include a software company valued at $186 million dollars as well as several other companies that brought in over $200 million in revenue throughout his executive career. Mr. Lisenby has been at the helm of MultiCorp since its inception in 2007 as XTend Medical. Mr. Lisenby holds a BA and MBA.

Ben Friedman - President
Mr. Friedman has worked in the medical and pharmacology business for over 35 years. A licensed pharmacist, Mr. Friedman has overseen developing several proprietary prescription compounds and several OTC medications throughout his career. In addition, Ben owned hotels and other properties he's developed. Ben also has been working in the capital markets since 2005 wherein his financial acumen has helped companies raise in excess of $15 million in private funding. Mr. Friedman currently holds a BA in business and is currently licensed to practice pharmacy in California and hold his board certification in pharmacology


 






 



 


 



 

AS info DE. Dept. of Corp. 

24/7 Phone: 302-739-3073, press #8 file number 3866564
http://www.corp.delaware.gov/default.shtml
Note: Web site does not give the AS. Must call, automated 24/7, or during business hours if one wishes to speak in person. 

Company Information

 MultiCorp International, Inc
10771 Sherman Way
Sun Valley, CA 91352
Phone: (818) 255-2476
Fax: (818) 255-2122

 Transfer Agent

Signature Stock Transfer, Inc.

2632 Coachlight Ct.
Plano, TX75093
Phone972-612-4120 Fax972-612-4122

Email - signaturestocktransfer@msn.com

      

 

This board is for discussing XMDC.
Information posted either positive or negative is accepted.
Personal attacks, repetitive, off topic posts or outright flame baiting posts are not accepted.
Posts that respond to PM (One way messages) are not allowed. Vulgarity is not acceptable. Violation of ones privacy is not acceptable.

Posts in violation of the rules will be deleted. Repeat offenders will be reported to the admins of IHUB.


Rules of the board per IHUB:
http://www.investorshub.com/boards/complex_terms.asp
 

 
Share structure

As of 06/18/08: 28,437,031 shares outstanding: 21,403,469 shares free trading: 7,033,562 shares restricted
As of 07/01/08: 28,437,031 shares outstanding: 21,403,469 shares free trading: 7,033,562 shares restricted
As of 07/03/08: 28,437,031 shares outstanding: 21,403,469 shares free trading: 7,033,562 shares restricted
As of 07/14/08: 28,437,031 shares outstanding: 21,403,469 shares free trading: 7,033,562 shares restricted
As of 07/16/08: 31,237,031 shares outstanding: 24,203,809 shares free trading: 7,033,562 shares restricted
As of 07/23/08: 36,737,031 shares outstanding: 30,057,796 shares free trading: 6,679,235 shares restricted; 150,000,000 shares Authorized.
As of 08/06/08: 36,737,031 shares outstanding: 30,057,796 shares free trading: 6,679,235 shares restricted; 150,000,000 shares Authorized.
As of 08/13/08: 36,737,031 shares outstanding: 30,057,796 shares free trading: 6,679,235 shares restricted; 150,000,000 shares Authorized.
As of 08/22/08: 86,737,031 shares outstanding: 80,057,796 shares free trading: 6,679,235 shares restricted; 1,000,000,000 shares Authorized.
As of 08/25/08: 101,737,031 shares outstanding: 95,057,796 shares free trading: 6,679,235 shares restricted; 1,000,000,000 shares Authorized.
As of 09/02/08: 245,737,031 shares outstanding: 239,489,809 shares free trading: 6,247,222 shares restricted; 1,000,000,000 shares Authorized.
As of 07/21/09: 256,737,031 shares outstanding: 239,065,599 shares free trading: 17,671,432 shares restricted; 1,000,000,000 shares Authorized.
As of 09/22/09: 256,737,031 shares outstanding: 239,065,599 shares free trading: 17,671,432 shares restricted; 1,000,000,000 shares Authorized.
As of 10/05/09: 616,737,031 shares outstanding: 299,065,600 shares free trading: 317,671,431 shares restricted; 1,000,000,000 shares Authorized.
As of 10/05/09: 616,737,031 shares outstanding: 299,065,600 shares free trading: 317,671,431 shares restricted; 1,000,000,000 shares Authorized.
As of 10/27/09: 636,737,031 shares outstanding: 319,497,611 shares free trading: 317,671,431 shares restricted; 1,000,000,000 shares Authorized.
As of 11/04/09: 649,737,031 shares outstanding: 332,065,600 shares free trading: 317,671,431 shares restricted; 1,000,000,000 shares Authorized.
As of 11/09/09: 766,487,031 shares outstanding: 351,681,600 shares free trading: 414,805,431 shares restricted; 1,000,000,000 shares Authorized.
As of 11/18/09: 770,487,031 shares outstanding: 355,681,600 shares free trading: 414,805,431 shares restricted; 1,000,000,000 shares Authorized.
As of 12/03/09: 783,137,031 shares outstanding: 370,891,600 shares free trading: 412,245,431 shares restricted; 1,000,000,000 shares Authorized.
As of 12/10/09: 986,490,863 shares outstanding: 378,391,600 shares free trading: 608,099,263 shares restricted; 1,000,000,000 shares Authorized.
As of 02/01/10: 986,490,863 shares outstanding: 390,766,744 shares free trading: 595,724,119 shares restricted; 1,000,000,000 shares Authorized.
As of 02/12/10: 986,490,863 shares outstanding: 390,766,744 shares free trading: 595,724,119 shares restricted; 1,000,000,000 shares Authorized.
As of 10/17/10: 986,490,863  shares outstanding: 390,766,744 shares free trading: 595,724,119 shares restricted; 1,750,000,000 shares Authorized.
As of 12/31/11  1,384,887,031 shares outstanding:462,855,646 shares free trading: 922,031,385 shares restricted:1,750,000,000 shares Authorized.
As of 08/30/12  984,887,031 shares outstanding: : 462,885,646 Free Trading : 1,750,000,000 shares Authorized.


SHAREHOLDERS' EQUITY, Per Company Balanced sheet
As of Sept 30, 2012 the company has 1,392,887,031
shares of common stock issued and outstanding.


 


 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MCIC
Current Price
Volume:
Bid Ask Day's Range
Wiki
MCIC News: MultiCorp International, Inc Expands Energy Division to Source Crude Oil Products for Global Sales 05/05/2014 09:15:00 AM
MCIC News: MultiCorp International, Inc. Engages BioRegenerative Sciences, Inc. & North County Clinical Research to Develop Clinical Tri... 04/17/2014 01:40:00 PM
PostSubject
#181260  Sticky Note It would be easier to get excited if k9narc 05/22/14 03:21:10 PM
#180822  Sticky Note MultiCorp International, Inc Expands Energy Division to Source sirant 05/05/14 09:06:03 AM
#180075  Sticky Note MULTICORP INTERNATIONAL, INC ENGAGES BIOREGENERATIVE SCIENCES, INC and 4u2nv2 04/16/14 10:32:02 AM
#182337   For those who want to report Lisenby for DKLN 07/25/14 08:55:23 PM
#182336   anyone who thinks mcic is a dead shell, chalmer 07/25/14 08:15:03 PM
#182335   K9narc...I was impressed also. I'm thinking on investing chalmer 07/25/14 05:00:02 PM
#182334   I think most either missed it or felt k9narc 07/25/14 04:52:39 PM
#182333   k9narc...Yeah, as I was thinking the same myself. chalmer 07/25/14 04:51:22 PM
#182332   I think most either missed it or felt k9narc 07/25/14 04:42:07 PM
#182331   k9narc...I must have missed that filing. It looks chalmer 07/25/14 03:15:32 PM
#182330   I must have missed all the discussions on k9narc 07/25/14 01:58:48 PM
#182329   I'm-definitely-the-BIG-trader-at-all-theMCIC-beer-infused-poker-fests…... in Sun Valley…….. ye h stringofpearls 07/25/14 12:56:40 PM
#182328   I made over 5,000% on my last sub hereigo 07/25/14 02:54:12 AM
#182327   Isn't it quite clear after all these months DKLN 07/24/14 11:14:12 PM
#182326   buy low sell high to those gorbec1 07/24/14 09:55:28 PM
#182325   Will the pps be doing that just like DKLN 07/24/14 06:10:51 PM
#182324   As usual, I see that Lisenby's BS spewed DKLN 07/24/14 06:04:08 PM
#182323   this stock at one point was .0003 gorbec1 07/24/14 12:11:40 PM
#182322   As usual any success that any investor has MLR_Lite 07/24/14 10:41:16 AM
#182321   Do you know that the Bioharp scam (e.g., DKLN 07/24/14 10:01:21 AM
#182320   Wait I had shares during bio harp. jmgotch 07/24/14 09:21:27 AM
#182319   maybe more than one really does gorbec1 07/23/14 11:59:11 PM
#182318   I don't mind holding shares in a possible MLR_Lite 07/23/14 09:15:06 PM
#182317   Is it the stock to own just like DKLN 07/23/14 08:29:20 PM
#182316   And if humans had wings, they could fly. DKLN 07/23/14 08:27:00 PM
#182315   IF the "EOCENE SYSTEM DISEASE MANAGEMENT&COMPLIANCE SYSTEM" they k9narc 07/23/14 07:27:28 PM
#182314   I am laughing every day thinking about all MLR_Lite 07/23/14 06:50:44 PM
#182313   mcic the stock to own gorbec1 07/23/14 06:46:39 PM
#182312   I am still waiting to find out if DKLN 07/23/14 06:12:23 PM
#182311   Yet, based on the atrocious pps and putrid DKLN 07/23/14 06:04:11 PM
#182310   More importantly, what BS will be included this DKLN 07/23/14 05:52:37 PM
#182309   $ MCIC GODZILLA IS ALIVE $$$$$$$$ I strongly disagree I sirant 07/23/14 03:56:18 PM
#182308   a hundred bags of worthlessness chalmer 07/23/14 03:19:36 PM
#182307   $MCIC GODZILLA IS ALIVE $$$$$$$$ sirant 07/23/14 02:19:11 PM
#182306   Well, who knows....sooner or later ones belief in k9narc 07/23/14 02:10:08 PM
#182305   $MCIC GODZILLA IS ALIVE $$$$$$$$$ I believe in PAUL and sirant 07/23/14 01:48:50 PM
#182304   No, but they are due to attempt something k9narc 07/23/14 01:42:16 PM
#182303   $MCIC GODZILLA IS ALIVE $$$$$$$$$$ sirant 07/23/14 01:23:09 PM
#182302   "If they couldn't why did they go in k9narc 07/23/14 01:07:47 PM
#182301   $MCIC GODZILLA IS ALIVE $$$4$$$$$$ sirant 07/23/14 12:48:11 PM
#182300   oh it can be done gorbec1 07/23/14 12:37:49 PM
#182299   "I am very curious to see if they k9narc 07/23/14 12:26:55 PM
#182298   $MCIC GODZILLA IS ALIVE $$$$$$$$$$ sirant 07/23/14 11:48:44 AM
#182297   Pr's from these clowns mean nothing. They need k9narc 07/23/14 11:37:13 AM
#182296   $MCIC GODZILLA IS ALIVE $$$$$$$$$ When will we see the sirant 07/23/14 11:29:38 AM
#182295   For those who want to report Lisenby for DKLN 07/23/14 07:19:36 AM
#182294   Since most heard the very wrong "it's 30 DKLN 07/21/14 10:23:56 PM
#182293   Someone's personal decision to buy sell or hold k9narc 07/21/14 09:45:29 PM
#182291   "Well u better look at all his business DKLN 07/21/14 07:30:08 PM
#182289   For those who want to report Lisenby for DKLN 07/21/14 06:14:12 PM
#182288   People living in reality will continue to call DKLN 07/21/14 05:45:02 PM
#182287   Some of us realized that from day 1 k9narc 07/21/14 03:24:43 PM
#182286   Yes, I finally came to that same conclusion CAretiree 07/21/14 02:53:25 PM
PostSubject